Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will provide a corporate update and ...

Several member banks of the Bankers Association of the Philippines (BAP) plan to acquire up to a 49-percent stake in the Philippine Dealing and Exchange ...

SEC Davao reminds corporations to comply with the 2025 deadlines for online submission of Annual Financial Statements (AFS) ...

In a widely expected move, the Trump administration will not defend a Biden-era Securities and Exchange Commission (SEC) climate disclosure ...

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the Company will host the second annual Contemporary Landscapes in Muscle Biology Research Symposium (CLIMB) on Friday, May 30 th, 2025 ...

MANILA, Philippines — The Philippine Stock ... the bond trading platform at P2.2 billion. However, the Securities and Exchange Commission (SEC) blocked the merger deal, saying that it would ...

Malik, M.D., Ph.D., Cytokinetics' Executive Vice President of Research ... to Cytokinetics' business outlines in Cytokinetics ...

The Securities and Exchange Commission (SEC) has been recognized by the Office of the President for its role in the ...

Detailed price information for Corbus Pharmaceuticals Hldgs Inc (CRBP-Q) from The Globe and Mail including charting and trades.

Q1 2025 Earnings Call Transcript May 13, 2025 Intellicheck, Inc. beats earnings expectations. Reported EPS is $-0.02, ...

May 08, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval Cohen, Ph.D., Chief Executive ... s filings with the ...

Genmab Announces Financial Results for the First Quarter of 2024May 8, 2025 Copenhagen, Denmark; Interim Report for the First Quarter Ended March 31, 2025HighlightsEPKINLY® (epcoritamab) approved by ...